Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |